Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |